AI assistant
IMMUNIC, INC. — Director's Dealing 2025
Jun 4, 2025
10196_dirs_2025-06-04_9f0b0bb8-30a2-44e3-a831-62762df0d089.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IMMUNIC, INC. (IMUX)
CIK: 0001280776
Period of Report: 2025-06-03
Reporting Person: Whaley Glenn (Chief Financial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-05-30 | Common Stock | A | 25000 | $0.56 | Acquired | 50510 | Direct |
| 2025-06-03 | Common Stock | P | 45000 | $0.7128 | Acquired | 95510 | Direct |
Footnotes
F1: The Reporting Person (RP) is voluntarily reporting the acquisition of shares of common stock pursuant to the Issuer's Employee Stock Purchase Plan (ESPP) in a transaction exempt under Rule 16b-3(c).
F2: In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of the Issuer's common stock on May 30, 2025.
F3: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.7127 to $0.7134. The RP undertakes to provide to the Issuer, any securityholder of the Issuer, or the SEC staff, upon request, information regarding the number of shares purchased at each price.